Xlumena, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 2008-01-01
- Employees
- 11
- Market Cap
- -
Clinical Trials
2
Active:0
Completed:2
Trial Phases
1 Phases
Not Applicable:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Not Applicable
2 (100.0%)AXIOS Stent With Electrocautery Enhanced Delivery System
Not Applicable
Completed
- Conditions
- Pancreatic Pseudocyst(s)
- First Posted Date
- 2014-05-23
- Last Posted Date
- 2015-10-02
- Lead Sponsor
- Xlumena, Inc.
- Target Recruit Count
- 30
- Registration Number
- NCT02146352
- Locations
- 🇺🇸
University of Colorado Denver, Aurora, Colorado, United States
🇺🇸Baptist Medical Center, Jacksonville, Florida, United States
🇺🇸Florida Hospital, Orlando, Florida, United States
AXIOS Stent & Delivery System Study
Not Applicable
Completed
- Conditions
- Pancreatic Pseudocyst(s)
- First Posted Date
- 2011-08-18
- Last Posted Date
- 2015-09-21
- Lead Sponsor
- Xlumena, Inc.
- Target Recruit Count
- 30
- Registration Number
- NCT01419769
- Locations
- 🇺🇸
California Pacific Medical Center (CPMC), San Francisco, California, United States
🇺🇸Unversity of Colorado Denver, Aurora, Colorado, United States
🇺🇸Borland-Groover Clinic, Jacksonville, Florida, United States
News
No news found